ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Study weighs risks and benefits of phase I trials in pediatric cancer
February 28, 2018On average, 1 in 10 children who enroll in pediatric phase I cancer trials are improved after the trial, and 1 in 50 die from drug-related complication -
Cancer experts urge reform of paediatric cancer trial rules
March 10, 2017Cancer experts are calling for a reform of outdated European regulations which they are argue are preventing cancer treatments from being trialled in children.
Pharma Sources Insight January 2025
